Home
News
Interviews
Companies
Videos
Markets
Subscribe
The
Latest
The Latest
News
Cybin to Announce Third Quarter Financial Results and Business Update on February 10, 2022
News
Nova Mentis and KGK Science Form Tactical Partnership
News
atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments
News
Core One Labs’ Akome Biotech Signs Research Agreement with University of Barcelona, Faculty of Pharmacy and Food Sciences
More Articles
FEATURED
Wellbeing Digital Sciences’ Subsidiary KGK Science Forms Tactical Partnership with Nova Mentis
News
Numinus Identified as a Licensed Psilocybin Supplier by Health Canada
Spotlight
Philip Young | CEO, Lobe Sciences
Trending
#
News
Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies
#
News
atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R-ketamine Program
#
Spotlight
Dr. Neil Maresky | CEO, Psyence Group
#
News
Psygen Receives Dealer's Licence from Health Canada
#
News
Cybin to Announce Third Quarter Financial Results and Business Update on February 10, 2022
Companies
#
Tryp Therapeutics
NEO
NASDAQ
CSE
TSXV
Private Company
#
Cybin Inc.
NEO
NASDAQ
CSE
TSXV
Private Company
#
Field Trip Health
NEO
NASDAQ
CSE
TSXV
Private Company
#
Numinus
NEO
NASDAQ
CSE
TSXV
Private Company
#
Mydecine Innovations Group
NEO
NASDAQ
CSE
TSXV
Private Company
